Correspondence on Effect of Different Doses of Sugammadex on Recovery and Hemodynamic Parameters in Reversing Neuromuscular Blockade in Patients Undergoing Electroconvulsive Therapy. [PDF]
Dogan AR.
europepmc +1 more source
Response to the Letter to the Editor Regarding Our Research Article on "Effect of Different Doses of Sugammadex on Recovery and Hemodynamic Parameters in Reversing Neuromuscular Blockade in Patients Undergoing Electroconvulsive Therapy". [PDF]
Arslan K, Sahin AS.
europepmc +1 more source
Bibliometric Analysis of Research Trends and Global Collaborations in Anesthesia on Neuromuscular Blockers and Antagonists (2000-2024). [PDF]
Evran T+3 more
europepmc +1 more source
Pillar[6]MaxQ and Sugammadex Enhance Recovery From Rocuronium- and Vecuronium-Mediated Neuromuscular Blockade With Similar Effects in Isoflurane-Anesthetized Rats. [PDF]
Cotten JF, Isaacs L.
europepmc +1 more source
Comparison of the Effects of Sugammadex Recommended Dose (2 mg/kg) and Fixed Dose of 200 mg on the Reversal of Moderate Neuromuscular Block and Recovery Profile in Adult Patients. [PDF]
Jung JY, Cho SA, Kwon W, Kim H, Sung TY.
europepmc +1 more source
Potential Adverse Effects of Sugammadex Administration: A Scoping Review. [PDF]
Liang WM+6 more
europepmc +1 more source
Safety and efficacy of sugammadex in management of patients with myasthenia gravis undergoing general anesthesia: A systematic review. [PDF]
Kaye AD+11 more
europepmc +1 more source
Anesthesia Management in a Crisponi Syndrome Patient Undergoing Tracheotomy Surgery. [PDF]
Celik E+4 more
europepmc +1 more source